Aegerion Sentenced To Pay Patients In Twist On $36M Plea
Patients harmed by a specialty cholesterol drug they were unnecessarily prescribed will get a slice of a $36 million forfeiture from Aegerion Pharmaceuticals Inc. instead of the government, a Massachusetts federal...To view the full article, register now.
Already a subscriber? Click here to view full article